(Bloomberg) — Some women who are at high risk of breast cancer, including those with a family history of the disease, should consider taking drugs to reduce their chances of getting cancer, a U.S. health advisory group says.

The drugs, tamoxifen and raloxifene, carry risks such as blood clots, stroke and cataracts, according to the U.S. Preventive Services Task Force, which released the draft recommendations on its website. The proposal is open for public comment until May 13.

Register or login for access to this item and much more

All Employee Benefit News content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access